Skip to main content
Log in

Prediction of Adverse Pregnancy Outcomes in Women with Systemic Lupus Erythematosus

  • Published:
Clinical Reviews in Allergy & Immunology Aims and scope Submit manuscript

Abstract

Systemic lupus erythematosus (SLE) is a chronic, autoimmune disease associated with major obstetrical complications such as gestational loss, preterm delivery, fetal growth restriction (FGR) and preeclampsia. Published literature is not consensual regarding the main risk factors for each of these outcomes. Our goal with this study was to determine the most important predictors for each of the main adverse pregnancy outcomes in this population. We conducted a retrospective cohort study of unifetal pregnancies of women with the diagnosis of SLE followed in our unit between January 1994 and December 2016. We excluded elective terminations of pregnancy and cases lost to follow-up and we analyzed 157 pregnancies (128 women). Multiple logistic regression models for the outcomes gestational loss, preterm delivery, fetal growth restriction, and preeclampsia were built. Two-sided p-values of < 0.05 were used to determine statistical significance, and two-sided confidence intervals of 95% are reported. In our cohort, the main risk factors for gestational loss were maternal age and the presence of antiphospholipid antibodies. Lupic nephritis was predictive of a preterm delivery and preeclampsia. Renal involvement and lupus flares during pregnancy were risk factors for FGR. Overall, the main risk factor for an adverse pregnancy outcome were lupus flares during pregnancy. Despite optimal pregnancy monitoring, women with SLE are still at risk for adverse pregnancy outcomes. Risk stratification for each of these outcomes is crucial for an effective counselling and tailored monitoring.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Rees F, Doherty M, Grainge MJ, Lanyon P, Zhang W (2017) The worldwide incidence and prevalence of systemic lupus erythematosus: a systematic review of epidemiological studies. Rheumatology (Oxford) 56(11):1945–1961

    Article  Google Scholar 

  2. Costenbader KH, Feskanich D, Stampfer MJ, Karlson EW (2007) Reproductive and menopausal factors and risk of systemic lupus erythematosus in women. Arthritis Rheum 56(4):1251–1262

    Article  Google Scholar 

  3. Cooper GS, Dooley MA, Treadwell EL, St Clair EW, Parks CG, Gilkeson GS (1998) Hormonal, environmental, and infectious risk factors for developing systemic lupus erythematosus. Arthritis Rheum 41(10):1714–1724

    Article  CAS  Google Scholar 

  4. Lateef A, Petri M (1994) Systemic lupus erythematosus and pregnancy. Rheum Dis Clin N Am 20(1):87–118

    Google Scholar 

  5. Clowse MEB, Jamison M, Myers E, James AH (2008) A national study of the complications of lupus in pregnancy. Am J Obstet Gynecol 199(2):127.e1–127.e6

    Article  Google Scholar 

  6. Peart E, Clowse MEB (2014) Systemic lupus erythematosus and pregnancy outcomes: an update and review of the literature. Curr Opin Rheumatol 26(2):118–123

    Article  CAS  Google Scholar 

  7. Liu J, Zhao Y, Song Y, Zhang W, Bian X, Yang J, Liu D, Zeng X, Zhang F (2012) Pregnancy in women with systemic lupus erythematosus: a retrospective study of 111 pregnancies in Chinese women. J Matern Fetal Neonatal Med 25(3):261–266

    Article  Google Scholar 

  8. Jara LJ, Medina G, Cruz-Dominguez P, Navarro C, Vera-Lastra O, Saavedra MA (2014) Risk factors of systemic lupus erythematosus flares during pregnancy. Immunol Res 60(2–3):184–192

    Article  CAS  Google Scholar 

  9. Tincani A, Allegri F, Balestrieri G, Reber G, Sanmarco M, Meroni P, Boffa MC (2004) Minimal requirements for antiphospholipid antibodies ELISAs proposed by the European forum on antiphospholipid antibodies. Thromb Res 114(5–6):553–558

    Article  CAS  Google Scholar 

  10. Brandt JT, Triplett DA, Alving B, Scharrer I (1995) Criteria for the diagnosis of lupus anticoagulant. Thromb Haemost 74(04):1185–1190

    Article  CAS  Google Scholar 

  11. Gayed M, Gordon C (2007 Nov 1) Pregnancy and rheumatic diseases. Rheumatology (Oxford) 46(11):1634–1640

    Article  CAS  Google Scholar 

  12. Ko HS, Ahn HY, Jang DG, Choi S-K, Park Y-G, Park IY, Lee G, Park SH, Shin JC (2011) Pregnancy outcomes and appropriate timing of pregnancy in 183 pregnancies in Korean patients with SLE. Int J Med Sci 8(7):577–583

    Article  Google Scholar 

  13. Uramoto KM, Michet CJ, Thumboo J, Sunku J, O’Fallon WM, Gabriel SE (1999) Trends in the incidence and mortality of systemic lupus erythematosus, 1950-1992. Arthritis Rheum 42(1):46–50

    Article  CAS  Google Scholar 

  14. Smyth A, Oliveira GHM, Lahr BD, Bailey KR, Norby SM, Garovic VD (2010) A systematic review and meta-analysis of pregnancy outcomes in patients with systemic lupus erythematosus and lupus nephritis. Clin J Am Soc Nephrol 5(11):2060–2068

    Article  Google Scholar 

  15. Ostensen M, Clowse M (2013) Pathogenesis of pregnancy complications in systemic lupus erythematosus. Curr Opin Rheumatol 25(5):591–596

    Article  CAS  Google Scholar 

  16. Ambrose N, Morgan TA, Galloway J, Ionnoau Y, Beresford MW, Isenberg DA (2016) Differences in disease phenotype and severity in SLE across age groups. Lupus. 25(14):1542–1550

    Article  CAS  Google Scholar 

  17. Clowse MEB, Magder LS, Witter F, Petri M (2005 Feb) The impact of increased lupus activity on obstetric outcomes. Arthritis Rheum 52(2):514–521

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Catarina R. Palma dos Reis.

Ethics declarations

Conflict of Interest

The authors declare that there are no conflicts of interest.

Ethical Approval

This was a retrospective, observational study that in our institution did not require specific ethics approval.

Informed Consent

This was a retrospective, observational study that in our institution, did not require specific informed consent.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic Supplementary Material

ESM 1

(DOCX 283 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Palma dos Reis, C.R., Cardoso, G., Carvalho, C. et al. Prediction of Adverse Pregnancy Outcomes in Women with Systemic Lupus Erythematosus. Clinic Rev Allerg Immunol 59, 287–294 (2020). https://doi.org/10.1007/s12016-019-08762-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12016-019-08762-9

Keywords

Navigation